A4PBio provide CRO oversight, project management and consultancy services in order to deliver regulatory compliant bioanalysis and bio-logistics solutions to the life science sector. A4PBio offer client-focused solutions in global laboratory selection, through assay development and validation, study sample analysis, data reporting and document review. Combining this with bespoke logistics solutions for the pro-actively managed transport of time and temperature critical biological samples and cell-based therapies. A4PBio's flexible and scalable resources, using considerable Pharmaceutical, Biotechnology and CRO experience, deliver individually built, cost effective, scientifically robust and regulatory compliant outsourcing or consultancy solutions.
Abcam is a producer and distributor of high quality protein research tools. Headquartered in Cambridge (UK), Abcam has subsidiary offices in Bristol (UK), Cambridge, MA (USA), Eugene, OR (USA), San Francisco, CA (USA), Tokyo (Japan), Hangzhou and Hong Kong (China), allowing it to serve a global customer base in over 130 countries. Abcam has an online catalogue of over 102,000 products sourced from over 400 suppliers. The catalogue includes a growing range of non-primary antibody products such as secondaries, proteins, peptides, lysates, immunoassays and other kits. Products are available for life science research and distributed to academic and commercial users.
Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. We invest across all stages of company development including early and late-stage venture financing, growth equity and public companies.. Founded in 1973, Abingworth has a lengthy track record of building market leading companies. Our specialist team of 19 professionals has a broad range of skills, including scientific and business expertise as well as investment banking, recruitment and legal knowledge. These resources are made available to portfolio companies. Abingworth has funds under management of over $1.25 billion and offices in London, Menlo Park (California) and Boston.
ABS is an expert at developing, validating and applying sophisticated techniques to quantify drugs, metabolites and biomarkers in biological fluids using LC-MS/MS and GC-MS. Our skills, experience and state-of-the-art equipment means that we can support a variety of studies small and large with a great attention to detail, customer service and turnaround times. We have a long list of validated methods in a variety of biological matrices. From plasma, urine and saliva to faeces, liver and even zebra fish brains, but our skills really lie in developing bespoke methods for new chemical entities.
Action for Innovation helps companies identify opportunities solve challenges and deliver innovation through internal projects and external collaborations. We design and execute programs for: opportunity identification, innovation strategy, technology evaluation, partnering and due diligence. Located in Cambridge we have run innovation project around the world, from Moscow to Mexico.
Agenda Life Sciences is a division of Agenda Resource Management Ltd a company that was established in 1996. Specialising in life science recruitment, contract staffing, permanent recruitment and security vetting and pre-employment checks, the company is well placed to be a one stop for added reassurance within the recruitment process for life science, scientific and pharmaceutical companies.. . Agenda has a wealth of specialist expertise, networks and databases in animal technology, biomedical and scientific sector enabling us to deliver the following solutions to common resourcing issues faced: . . •
Agenus, Inc. (www.agenusbio.com) is an immuno-oncology company focused on the discovery and development of revolutionary new treatments that engage the body's immune system to benefit cancer patients. By combining multiple powerful platforms, Agenus has established a highly integrated approach for the discovery, development and manufacture of monoclonal antibodies that modulate targets of interest. In addition, Agenus' cancer vaccine programme includes three proprietary platforms focused on individualised and off-the-shelf vaccines uniquely designed for each patient. Agenus' broad portfolio of novel checkpoint and other immuno-modulatory monoclonal antibodies, vaccines and adjuvants work in combination to provide the opportunity to create best-in-class therapeutic regimens.
We support our Clients by navigating through technical challenges, translating data into strategy and communication, and revealing the impact of their science.
SBC Tenant Comp. . Aglaris Ltd produce equipment to ensure cell and tissue culture is an easy, problem-free task. By automating and controlling the cell culture processes, we have the tools to obtain cells and tissues with sufficient quality to revitalise regenerative medicine and cell therapies. The technology used by our equipment is unique and is protected by international patents.